Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $10.31 USD
Change Today +0.14 / 1.38%
Volume 7.8K
TRIV On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher G. Chavez

Chairman, Chief Executive Officer and President, TriVascular Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 4 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Christopher G. Chavez, also known as Chris is a Co-Founder of TriVascular Technologies, Inc. and has been its Chairman of the Board, Chief Executive Officer and President since April 2012. Mr. Chavez has been Chairman of the Board, Chief Executive Officer and President of TV2 Holding Company since April 2012. Mr. Chavez joined St. Jude in 2005 when it acquired Advance Neuromodulation Systems. Mr. Chavez served as Chief Executive Officer and the President of Advanced ...

Read Full Background

Corporate Headquarters*

3910 Brickway Boulevard
Santa Rosa, California 95403

United States

Phone: 707-543-8800
Fax: --

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer and President
Chief Executive Officer, President and Director
Former Director, Member of Organization, Compensation & Corporate Governance Committee, Member of Science & Technology Committee, Chief Executive Officer of Advanced Neuromodulation Systems, President of Advanced Neuromodulation Systems and Director of Advanced Neuromodulation Systems
Chairman, Chief Executive Officer and President


MBA 1979
Harvard Business School
Bachelor's Degree
New Mexico State University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$450,000

Stock Options*

All Other Compensation$2,974
Exercisable Options29,720
Exercisable Options Value$228,844
Unexercisable Options168,865
Unexercisable Options Value$341,107
Total Value of Options$569,951
Total Number of Options198,585

Total Compensation*

Total Annual Cash Compensation$452,974
Total Short Term Compensation$450,000
Other Long Term Compensation$2,974
Total Calculated Compensation$1,305,771
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRIV:US $10.31 USD +0.14


Timothy M. Ring Chairman, Chief Executive Officer and Chairman of Executive Committee
CR Bard Inc.
Daniel J. Starks Chairman, Chief Executive Officer and President
St. Jude Medical Inc.
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
John McDermott MBAChairman of the Board and Chief Executive Officer
Endologix Inc.
Simon Hubbert Chief Executive Officer and Director
Lombard Medical, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRIVASCULAR TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at